Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current


Tiziana Life Sciences Receives FDA Acceptance For Fast Track Designation Submission Of Intranasal Foralumab For Treating Non-Active Secondary-Progressive Multiple Sclerosis (na-SPMS)

Author: Benzinga Newsdesk | June 11, 2024 08:06am

Posted In: TLSA